Gyre Therapeutics, Inc. - Common Stock (NQ:GYRE)
Price and Volume
Detailed Quote| Volume | 56,024 |
| Open | 6.440 |
| Bid (Size) | 6.750 (1,000) |
| Ask (Size) | 6.950 (100) |
| Prev. Close | 6.440 |
| Today's Range | 6.410 - 6.890 |
| 52wk Range | 5.440 - 9.420 |
| Shares Outstanding | 37,759,825 |
| Dividend Yield | N/A |
Top News
More News
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
September 03, 2026
Via GlobeNewswire
Performance
| YTD |
+0.7%
|
+0.7%
|
| 1 Month |
+10.1%
|
+10.1%
|
| 3 Month |
+9.1%
|
+9.1%
|
| 6 Month |
-11.0%
|
-11.0%
|
| 1 Year |
-9.5%
|
-9.5%
|
More News
Read More
Earnings Scheduled For November 7, 2025 ↗
November 07, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 10, 2025
Via Benzinga
Frequently Asked Questions
Is Gyre Therapeutics, Inc. - Common Stock publicly traded?
Yes, Gyre Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Gyre Therapeutics, Inc. - Common Stock trade on?
Gyre Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gyre Therapeutics, Inc. - Common Stock?
The ticker symbol for Gyre Therapeutics, Inc. - Common Stock is GYRE on the Nasdaq Stock Market
What is the current price of Gyre Therapeutics, Inc. - Common Stock?
The current price of Gyre Therapeutics, Inc. - Common Stock is 6.860
When was Gyre Therapeutics, Inc. - Common Stock last traded?
The last trade of Gyre Therapeutics, Inc. - Common Stock was at 09/04/26 04:00 PM ET
What is the market capitalization of Gyre Therapeutics, Inc. - Common Stock?
The market capitalization of Gyre Therapeutics, Inc. - Common Stock is 259.03M
How many shares of Gyre Therapeutics, Inc. - Common Stock are outstanding?
Gyre Therapeutics, Inc. - Common Stock has 259M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>